Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins

Multiple Sclerosis Journal

Volumn 17, Issue 11, 2011, Pages 1290-1294

  Mechelli, R ^a   Anderson, J ^b   Vittori, D ^a   Coarelli, G ^a   Annibali, V ^a   Cannoni, S ^a   Aloisi, F ^c   Salvetti, M ^a   James, J A ^b   Ristori, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

antibodies; B cell epitope; Epstein Barr virus nuclear antigen 1; infectious mononucleosis; monozygotic twins; multiple sclerosis

Indexed keywords

EPITOPE; EPSTEIN BARR VIRUS ANTIGEN 1;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNE RESPONSE; INFECTIOUS MONONUCLEOSIS; MALE; MONOZYGOTIC TWINS; MULTIPLE SCLEROSIS; NONHUMAN; SEROLOGY; TWIN DISCORDANCE;

EID: 80655144768     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511410515     Document Type: Article

References (24)

1. Pender MP. Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?. Brain. 2009 ; 132: 3196-3198
2. Ascherio A, Bar-Or A. EBV and brain matter(s)?. Neurology. 2010 ; 74: 1127-1135
3. Sundström P, Nyström M, Ruuth K, Lundgren E. Antibodies to specific EBNA-1 domains and HLA-DRB1*1501 interact as risk factors for multiple sclerosis. J Neuroimmunol. 2009 ; 215: 102-107
4. Jafari N, van Nierop GP, Verjans GMGM, Osterhaus AD, Middeldorp JM, Hintzen RQ. No evidence of intrathecal IgG synthesis to Epstein-Barr virus nuclear antigen-1 in multiple sclerosis. J Clin Virol. 2010 ; 49: 26-31
5. Simon KC, van der Mei IA, Munger KL, Ponsonby A, Dickinson J, Dwyer T, et al. Combined effects of smoking, anti EBNA-1 antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology. 2010 ; 74: 1365-1371
6. Baranzini SE, Mudje J, van Velkinburg JC, Khankhanian P, Khrebtukova I, Miller NA, et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature. 2010 ; 464: 1351-1356
7. Ristori G, Cannoni S, Stazi MA, Vanacore N, Cotichini R, Alfò M, et al. Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study. Ann Neurol. 2006 ; 59: 27-34
8. McClain MT, Rapp EC, Harley JB, James JA. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J Med Virol. 2003 ; 70: 253-257
9. James JA, Harley JB. Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns. J Immunol. 1996 ; 156: 4018-4026
10. McClain MT, Poole BD, Bruner BF, Kaufman KM, Harley JB, James JA. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 360-368
11. Ristori G, Mechelli R, Anderson J, Mengoni F, Sauzullo I, Annibali V, et al. Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins. Mult Scler. 2010 ; 12: 1527-1528
12. Rhodes G, Rumpold H, Kurki P, Patrick KM, Carson DA, Vaughan JH. Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen. J Exp Med. 1987 ; 165: 1026-1040
13. Van Noort JM, Van Sechel AC, Bajramovic JJ, el Ouagmiri M, Polman CH, Lassmann H, et al. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature. 1995 ; 375: 798-801
14. Van Sechel AC, Bajramovic JJ, van Stopdonk MJ, Persoon-Deen C, Geutskens SB, van Noort JM. EBV-induced expression and HLA-DR restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol. 1999 ; 162: 129-135
15. Rand KH, Houck H, Denslow ND, Heilman KM. Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998 ; 65: 48-55
16. Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infections in humans: lessons from Epstein-Barr virus. Annu Rev Immunol. 2007 ; 25: 587-617
17. Lünemann JD, Huppke P, Roberts S, Brück W, Gärtner J, Münz C, et al. Broadened and elevated humoral immune response to EBNA-1 in pediatric multiple sclerosis. Neurology. 2008 ; 71: 1033-1035
18. Munch M, Hvas J, Christensen T, Møller-Larsen A, Haar S. A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand. 1998 ; 98: 195-199
19. Lindsey JW, Patel S, Zou J. Epstein-Barr virus genotypes in multiple sclerosis. Acta Neurol Scand. 2008 ; 117: 141-144
20. Brennan RM, Burrows JM, Bell MJ, Bromham L, Csurhes PA, Lenarczyk A, et al. Strains of Epstein-Barr virus infecting multiple sclerosis patients. Mult Scler. 2010 ; 6: 643-651
21. Simon KC, Yang Y, Munger KL, Ascherio A. EBNA1 and LMP1 variants in multiple sclerosis cases and controls. Acta Neurol Scand. 2010 ;:
22. Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim SK, Clute SC, et al. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev. 2006 ; 211: 164-181
23. Lünemann JD, Jelcic I, Roberts S, Lutterotti A, Tackenberg B, Martin R, et al. EBNA-1 specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med. 2008 ; 205: 1763-1773
24. Recher M, Lang KS, Navarini A, Hunziker L, Lang PA, Fink K, et al. Extralymphatic virus sanctuaries as a consequence of potent T cell activation. Nat Med. 2007 ; 13: 1316-1323